Because repeated and enhanced expression of E6 and E7 results in cell immortalization and transformation [30, 31], it is intriguing that O-GlcNAc modification of HCF-1 increases E6 and E7 transcription in cervical cancer, where E6 and E7 can be targeted for immune therapy. Here, HCFC1 is linked to cervical cancer.